Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (29)
  • Autophagy
    (21)
  • Antibacterial
    (16)
  • Adrenergic Receptor
    (12)
  • 5-HT Receptor
    (11)
  • Dopamine Receptor
    (11)
  • Endogenous Metabolite
    (11)
  • Antibiotic
    (10)
  • Parasite
    (9)
  • Others
    (173)
Filter
Search Result
Results for "

therapy

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    464
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    18
    TargetMol | Compound_Libraries
  • Peptide Products
    16
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    8
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    9
    TargetMol | Dye_Reagents
  • PROTAC Products
    10
    TargetMol | PROTAC
  • Natural Products
    63
    TargetMol | Natural_Products
  • Recombinant Protein
    80
    TargetMol | Recombinant_Protein
  • Isotope Products
    14
    TargetMol | Isotope_Products
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Cell Research
    18
    TargetMol | Inhibitors_Agonists
Salmeterol Xinafoate
Salmetedur, GR 33343X xinafoate, Arial
T665394749-08-3
Salmeterol Xinafoate (GR 33343X xinafoate) is a long-acting β2-adrenergic receptor agonist with anti-inflammatory effects, used in the treatment of asthma symptoms and chronic obstructive pulmonary disease (COPD) symptoms.
  • Inquiry Price
Size
QTY
Salmeterol
GR33343X
T1282989365-50-4
Salmeterol (GR33343X) is a long-acting agonist of beta2-adrenergic receptor (beta 2AR) used for treatment ofasthma.
  • Inquiry Price
Size
QTY
DMG-PEG 2000
DMG-PEG2000
T9098160743-62-4
DMG-PEG 2000 (DMG-PEG2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Formulations containing DMG-PEG 2000 have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Edaravone
MCI-186
T040789-25-8
Edaravone (MCI-186) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Verteporfin
CL 318952, BPD-MA
T3112129497-78-5
Verteporfin (BPD-MA) is a YAP inhibitor that inhibits YAP-TEAD interactions. Verteporfin is also a photosensitizer used in photodynamic therapy. Verteporfin also induces apoptosis and inhibits autophagy.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
vt107
T355452417718-63-7In house
VT107 is a potent pan-TEAD autopalmitoylation inhibitor. VT-107 can be used in cancer therapy research.[1]
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Hot
Elimusertib
BAY-1895344
T73181876467-74-1
Elimusertib (BAY-1895344) is a potent, highly selective, and orally available ATR inhibitor with an IC50 of 7 nM, demonstrating significant anti-tumor efficacy as a monotherapy and strong combination potential with targeted alpha therapy Radium-223 dichloride.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
DT-061
T10060L1809427-19-7In house
DT-061, an orally bioavailable protein phosphatase 2A (PP2A) activator, may be used in the therapy of KRAS-mutant and MYC-driven tumorigenesis.
  • Inquiry Price
8-10 weeks
Size
QTY
GSK-843
GSK'843
T114741601496-05-2In house
GSK-843 (GSK'843) is a selective and potent RIP3 inhibitor with an IC50 value of 8.6 nM for the structural domain of RIP3 kinase. It has potential analgesic activity, inhibits the expression of RIP3 and NLRP3 in the SDH of CFA mice, and can be used as adjunctive therapy for treating inflammation.
  • Inquiry Price
7-10 days
Size
QTY
PPA-904
T1952530189-85-6In house
PPA-904, a specific phenothiazine photosensitizer, is used in photodynamic therapy (PDT).
  • Inquiry Price
7-10 days
Size
QTY
Itasetron
DAU6215CL, UNII-00S0D0OEKR, U-98079A, U 98079A, DAU 6215CL
T24184123258-84-4In house
Itasetron (U 98079A) is a 5-hydroxytryptamine 3-receptor antagonist used to prevent age-related memory deficits in rats.Itasetron's antiemetic activity in animal models of cancer chemotherapy and radiation therapy may be useful in the study of amnesia.
  • Inquiry Price
6-8weeks
Size
QTY
TargetMol | Inhibitor Sale
VX-702
479543-46-9
T2513745833-23-2In house
VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).
  • Inquiry Price
7-10 days
Size
QTY
GS-9667
CVT-3619, CVT 3619
T27439618380-90-8In house
GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA).
  • Inquiry Price
6-8weeks
Size
QTY
TargetMol | Inhibitor Sale
Rabeximod
ROB-803
T34249872178-65-9In house
Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
Seridopidine
ACR-343, ACR 343, ACR343
T34616883631-51-4In house
Seridopidine (ACR343) is a modulator of dopaminergic activity that is used as an oral therapy for schizophrenia, Parkinson's disease, and Tourette's syndrome.
  • Inquiry Price
6-8weeks
Size
QTY
TargetMol | Inhibitor Sale
TargetMol
Laromustine
VNP 40101M, VNP40101M
T70229173424-77-6In house
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity. Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.
  • Inquiry Price
6-8 weeks
Size
QTY
MSU-42011
T774992456434-36-7In house
MSU-42011 is an orally active retinoid X receptor-like (RXR) agonist. It potently inhibits the expression of iNOS, low SREBP-induced and activated RXR, and p-ERK at the protein level. MSU-42011 has demonstrated antitumor activity in a [kras]-driven mouse model of lung cancer and is effective for the treatment of preclinical [kras]-driven lung cancer with immunomodulatory activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Nothofagin
TN199611023-94-2In house
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
  • Inquiry Price
8-10 weeks
Size
QTY
Sulfalene
Sulfalene(SMPZ), Butadiene sulfone, SMP2, AS-18908, Sulfametopyrazine, Sulfalen, 3-Sulfolene
T0026152-47-6
Sulfalene (SMP2), a long-acting sulfonamide antibiotic, is used for the therapy of chronic bronchitis, urinary tract infections, and malaria.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Heptaminol hydrochloride
RP-2831 hydrochloride
T0045543-15-7
Heptaminol hydrochloride (RP-2831 hydrochloride), a vasoconstrictor, is used in the therapy of hypotension, especially orthostatic hypotension.
  • Inquiry Price
Size
QTY
Glafenine
Glafenin
T00553820-67-5
Glafenine (Glafenin), a non-narcotic analgesic agent, is a non-steroidal anti-inflammatory drug (NSAID), and widely used for the therapy of pains of various origins.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Lapatinib ditosylate monohydrate
Lapatinib ditoluenesulfonate monohydrate, Tyverb ditosylate monohydrate, Lapatinib ditosylate monohydrate, Lapatinib ditosilate hydrate, Tykerb ditosylate monohydrate
T0078L388082-78-8
Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.
  • Inquiry Price
Size
QTY
Entecavir
BMS200475, SQ34676
T0085L142217-69-4
Entecavir (SQ34676) is a guanosine nucleoside analogue used in the treatment of chronic hepatitis B virus (HBV) infection. Entecavir therapy can be associated with flares of the underlying hepatitis B during or after therapy, but has not been linked to cases of clinically apparent liver injury.
  • Inquiry Price
Size
QTY
Cetirizine dihydrochloride
UCB P071, P071, Cetirizine DiHCl
T008983881-52-1
Cetirizine dihydrochloride (UCB P071) is an effective second-generation histamine H1 antagonist that is potent in the therapy of allergic rhinitis, confirmed urticaria, and pollen-induced asthma. Unlike other conventional antihistamines, it does not cause side effects of drowsiness or anticholinergic.
  • Inquiry Price
Size
QTY